Cargando…
Transcriptional data: a new gateway to drug repositioning?
Recent advances in computational biology suggest that any perturbation to the transcriptional programme of the cell can be summarised by a proper ‘signature’: a set of genes combined with a pattern of expression. Therefore, it should be possible to generate proxies of clinicopathological phenotypes...
Autores principales: | Iorio, Francesco, Rittman, Timothy, Ge, Hong, Menden, Michael, Saez-Rodriguez, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625109/ https://www.ncbi.nlm.nih.gov/pubmed/22897878 http://dx.doi.org/10.1016/j.drudis.2012.07.014 |
Ejemplares similares
-
A Semi-Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning Predictions
por: Iorio, Francesco, et al.
Publicado: (2015) -
Repositioning the Chemical Information Science Gateway
por: Bajorath, Jürgen
Publicado: (2019) -
Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
por: Menden, Michael P., et al.
Publicado: (2013) -
Network based elucidation of drug response: from modulators to targets
por: Iorio, Francesco, et al.
Publicado: (2013) -
The germline genetic component of drug sensitivity in cancer cell lines
por: Menden, Michael P., et al.
Publicado: (2018)